QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
27.08
+1.89 (7.50%)
Aug 13, 2025, 4:00 PM - Market closed
QuidelOrtho Employees
QuidelOrtho had 6,600 employees as of December 29, 2024. The number of employees decreased by 500 or -7.04% compared to the previous year.
Employees
6,600
Change (1Y)
-500
Growth (1Y)
-7.04%
Revenue / Employee
$415,394
Profits / Employee
-$70,667
Market Cap
1.84B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QDEL News
- 18 hours ago - QuidelOrtho Launches Certified Analyzer Program - PRNewsWire
- 8 days ago - QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - QuidelOrtho Reports Second Quarter 2025 Financial Results - PRNewsWire
- 15 days ago - QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™ - PRNewsWire
- 21 days ago - Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast - PRNewsWire
- 22 days ago - QuidelOrtho to Report Second Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Real Labs, Actual Decisions With Actionable Six Sigma Metrics - PRNewsWire
- 4 weeks ago - QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA) - PRNewsWire